Osteopro 30 pcs
OsteoproOSTEOPRO mineral complex is recommended to supplement calcium deficiency in the body, in osteoporosis and to accelerate bone fusion in fractures. The mineral part is represented by calcium, phosphorus and other elements that promote the full absorption of calcium from the gastrointestinal tract and improve its fixation in the bones. The organic component includes proteins that enhance the osteogenic effect.
Indications for use (instruction): Osteopro 30 pcs
OSTEOPRO® is an additional source of calcium, phosphorus, proteins (collagen, growth factors, osteocalcin) and vitamins D3 and K2. It is recommended to regulate calcium-phosphorus metabolism in case of calcium deficiency in the body, osteoporosis, and to improve bone growth in case of fractures.
How to use
In case of fractures: from the first day of the fracture and for 14 days, it is recommended to take 1 tablet per day with a small amount of drinking water, preferably during meals. From the 15th day, it is recommended to switch to taking 2 tablets per day (in 2 divided doses) with a small amount of drinking water, preferably during meals. The tablets can be chewed to make swallowing easier. On the recommendation of a doctor, the recommended daily dose may be increased. The course of application is determined individually. The minimum recommended course of application is 1 month. It is recommended to consult a doctor before use.
In other conditions, in order to regulate calcium-phosphorus metabolism, with a calcium deficiency in the body, osteoporosis: take for adults 2-4 tablets per day (in 2 divided doses) with a small amount of drinking water, preferably during meals. The tablets can be chewed to make swallowing easier. On the recommendation of a doctor, the recommended daily dose may be increased. The course of application is determined individually. The minimum recommended course of application is 1 month. It is recommended to consult a doctor before use.
Contraindications
Іndividual sensitivity to any of the components, hypercalcemia, hypercalciuria, urolithiasis, tissue calcification, severe renal dysfunction, hyperproliferative processes, hypervitaminosis of vitamin D.
Composition
1 tablet contains the active ingredient: microcrystalline hydroxyapatite complex MSNAtm (MSH-Saltm) - 1000 mg (mg), vitamin K2 (menaquinone-7) - 25 μg (μg), vitamin D3 (cholecalciferol) - 12.5 μg (μg) (500 IU (IU)); auxiliary substances: fillers: microcrystalline cellulose, CompactCel® (hydroxypropyl cellulose, sodium carboxymethyl cellulose), anti-caking agent: magnesium stearate.
MSNAtm (MSN-Saltm) - includes 250 mg (mg) of proteins (type I collagen and non-collagen peptides, including type I and II insulin-like growth factor (IGF1 - 0.285 μg (µg), IGF2 - 0.17 μg (µg)), transforming growth factor beta (TGF-β - 0.0275 μg (µg)), osteocalcin - 604 μg (µg)) and 670 mg (mg) calcium hydroxyapatite (including 250 mg (mg) calcium, 125 mg (mg ) phosphorus, 4 mg (mg) magnesium, 64 μg (µg) zinc, 3.9 μg (µg) iron and 1.4 μg (µg) boron)*
**typical average content of components.
GMO-free
Release form
Tablets weighing 1.5 g ± 7.5%, 30 or 60 tablets in a jar packed in a cardboard box.
Manufacturer
Dr. Gustav Klein GmbH & Co. KG, Германии.
Sanitary and hygienic conclusion
№43 dated 31.07.2020
This product is not a drug.